Scholar Rock Holding Corporation (SRRK) Stock

Scholar Rock Holding Corporation (SRRK) is a Healthcare stock trading at $47.30 (as of 2026-06-18), with a market capitalization of $5.91B and a trailing P/E of -14.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Scholar Rock Holding Corporation is a biopharmaceutical company developing therapies that target protein growth-factor signaling. Its programs include apitegromab for spinal muscular atrophy (Phase 3) and SRK-181 for certain cancers resistant to checkpoint inhibitor antibodies (Phase 1), alongside a pipeline spanning neuromuscular disorders, cancer, and fibrosis, including collaboration with Gilead Sciences on inhibitors of TGF-beta activation.

Valuation — source: SEC EDGAR (first-party)
Price$47.30
Market Cap$5.91B
P/E Ratio-14.3
EV / EBITDA-13.9
Price / Book21.40
DCF Value (model)$-42.57
DCF Upside vs Price-190.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$0.00
Return on Equity-148.1%
Debt / Equity0.72
Current Ratio8.64
Financial Health — source: SEC EDGAR
Altman Z-Score13.87 (safe)
Valuation vs Sector & Industry
Stock P/E-14.3
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-168.2%
vs Industry-182.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($847.67M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEODavid L. Hallal
Employees128
CountryUS
IPO Date2018-05-25

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Apogee Therapeutics, Inc. (APGE)
  • Immunovant, Inc. (IMVT)
  • CRISPR Therapeutics AG (CRSP)
  • Arrowhead Pharmaceuticals, Inc. (ARWR)
  • Alkermes plc (ALKS)
  • Indivior Pharmaceuticals Inc (INDV)
  • ACADIA Pharmaceuticals Inc. (ACAD)
  • Crinetics Pharmaceuticals, Inc. (CRNX)
SRRK earnings history · SRRK institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.